Search research articles
Contact Us
Filters
Showing results (101-110 of 169) with videos related to
Page
of 17
Sort By:
Journal of the National Cancer Institute
|
November 20, 2024
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling
Yibai Zhao, Roman Gulati, Zhenwei Yang, et al.
The American Journal of Pathology
|
October 29, 2022
Genomic Characterization of Prostatic Basal Cell Carcinoma
Jin-Yih Low, Minjeong Ko, Brian Hanratty, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Determining preclinical safety of Aclarubicin in pediatric malignancies
Darleen S Tu, Aaron K Olson, Kimberly S Waggie, et al.
Cancer Research Communications
|
December 19, 2023
FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer
Oluwademilade Dairo, Lia DePaula Oliveira, Ethan Schaffer, et al.
Molecular Cancer Research : MCR
|
October 16, 2019
Functional Loss of <i>ATRX</i> and <i>TERC</i> Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
Mindy K Graham, Jiyoung Kim, Joseph Da, et al.
The Journal of Clinical Investigation
|
October 19, 2013
Tracking the clonal origin of lethal prostate cancer
Michael C Haffner, Timothy Mosbruger, David M Esopi, et al.
Pediatric Blood & Cancer
|
November 27, 2025
Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies
Darleen S Tu, Aaron K Olson, Kimberly S Waggie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 13, 2014
Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas
Hsueh-Li Tan, Michael C Haffner, David M Esopi, et al.
The Prostate
|
August 17, 2021
Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer
Michael C Haffner, Akshay Bhamidipati, Harrison K Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer
Diana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 169) with videos related to
Sort By:
Page
of 17
Journal of the National Cancer Institute
|
November 20, 2024
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling
Yibai Zhao, Roman Gulati, Zhenwei Yang, et al.
The American Journal of Pathology
|
October 29, 2022
Genomic Characterization of Prostatic Basal Cell Carcinoma
Jin-Yih Low, Minjeong Ko, Brian Hanratty, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Determining preclinical safety of Aclarubicin in pediatric malignancies
Darleen S Tu, Aaron K Olson, Kimberly S Waggie, et al.
Cancer Research Communications
|
December 19, 2023
FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer
Oluwademilade Dairo, Lia DePaula Oliveira, Ethan Schaffer, et al.
Molecular Cancer Research : MCR
|
October 16, 2019
Functional Loss of <i>ATRX</i> and <i>TERC</i> Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
Mindy K Graham, Jiyoung Kim, Joseph Da, et al.
The Journal of Clinical Investigation
|
October 19, 2013
Tracking the clonal origin of lethal prostate cancer
Michael C Haffner, Timothy Mosbruger, David M Esopi, et al.
Pediatric Blood & Cancer
|
November 27, 2025
Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies
Darleen S Tu, Aaron K Olson, Kimberly S Waggie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 13, 2014
Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas
Hsueh-Li Tan, Michael C Haffner, David M Esopi, et al.
The Prostate
|
August 17, 2021
Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer
Michael C Haffner, Akshay Bhamidipati, Harrison K Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer
Diana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
Page
of 17